In human beings, CD4+ and CD8+ cytotoxic T lymphocytes are well-suited for the destruction of glioma cells due to their ability to recognize specific tumor antigens on the cell surface and have been shown to correlate with tumor inhibition and tumor regression (37). The gene discussed is CD4; the disease is neoplasm.